Endoscopic ultrasound (EUS) has transformed the evaluation of pancreatic disease by combining high-resolution imaging with targeted tissue acquisition. Two principal approaches—fine-needle aspiration ...

510(k) Clearance of first-of-kind Endoscopic Ultrasound (EUS) technology Paves the way for safer and more accessible medical care EndoSound will begin its controlled market release in early Q1 2024 ...

Background A 72-year-old white male presented to a University Digestive Disease Center with epigastric pain and weight loss. A CT scan suggested that the patient had a mass in his pancreas and he was ...

Advancing Endoscopic Ultrasound Imaging to Support Early, Informed Clinical Decision‑Making TOKYO and TUSTIN, Calif., May 1, 2026 /PRNewswire/ -- Olympus Corporation and Canon Medical Systems USA, Inc ...

A new business intelligence report released by Allied Market Research, the global Endoscopic Ultrasound (EUS) Market size generated $1.2 billion in 2021, and is expected to reach $2.2 billion by 2031, ...

J Gastroenterol Hepatol. 2009;24(4):509-519. One of the most important issues may be the introduction of rapid staining performed by a cytopathologist or cytotechnician during the procedure. Aspirated ...

Endoscopic ultrasonography (EUS) is one of the most recent advances in gastrointestinal endoscopy. Available EUS devices include echoendoscopes, such as radial scanning and linear array echoendoscopes ...

A pancreatic biopsy is a diagnostic test for pancreatic cancer. It involves taking a sample of cells from tissue or a tumor in the pancreas and sending it for laboratory analysis. Types of biopsy for ...

Phase I trial of nab-paclitaxel administered concurrently with radiotherapy in patients with locally advanced inoperable pancreatic adenocarcinoma (ART in LAP). This is an ASCO Meeting Abstract from ...

Sisters with family history among first to test new screening technology designed to detect abnormalities before cancer ...

Correlation of blood levels of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor and hemoglobin with response to therapy in advanced non-small cell lung cancer patients ...

PORTLAND, Ore.--(BUSINESS WIRE)--EndoSound® Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce it has received 510(k) clearance from the FDA for ...